Areas of Focus
- 造血调控及白血病发生机理
- NK细胞免疫治疗
Work Experience
- 2019年至今 - 中国科学技术大学生命科学与医学部,首席研究员
Academic Background & Achievements
- 2013年 - 博士学位:中国科学技术大学生命科学学院
- 2015年至2019年 - 博士后研究:美国Emory大学医院
Publications
- Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia., Wang Y, Huang B, Liang T, Jiang L, Wu M, Liu X, Zhu M, Song X, Zhao N, Wei H*, Zheng C*, Ni F*., 2024
- Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19., Guo C#, Wu M#, Huang B#, Zhao R, Jin L, Fu B, Wang P, Wang D, Zheng M, Fang J, Wei H*, Qu K*, Ni F*., 2022
- Ptpn21 controls hematopoietic stem cell homeostasis and biomechanics., Ni F, Yu WM, Wang XY, Fay ME, Young KM, Qiu YZ, Lam WA, Sulchek TA, Cheng T, Scadden DT, and Qu CK*., 2019
- Critical role of ASCT2-mediated amino acid metabolism in promoting leukemia development and progression., Ni F, YuWM, Li ZG, GrahamDK, JinLT, Kang S, RossiMR, LiSY, BroxmeyerHE, and Qu CK*., 2019
- IGF-1 promotes the development and cytotoxic activity of human NK cells., Ni F, Sun R, Fu B, Wang F, Guo C, Tian Z*, Wei H*., 2013